878292-27-4 Usage
General Description
7-Fluoro-3,4-dihydro-4-[(5-isoquinolinyloxy)acetyl]-1,3,3-trimethyl-2(1H)-quinoxalinone is a chemical compound with potential pharmacological properties. It is a quinoxalinone derivative and has a fluorine atom at the 7th position, as well as a 4-[(5-isoquinolinyl)oxyacetyl] group at the 4th position. 7-Fluoro-3,4-dihydro-4-[(5-isoquinolinyloxy)acetyl]-1,3,3-trimethyl-2(1H)-quinoxalinone may have potential applications in medicinal chemistry, particularly in the development of drugs for various conditions. Its exact mechanisms of action and specific uses are yet to be fully elucidated, but its unique structure and potential biological activities make it an interesting target for further research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 878292-27-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,8,2,9 and 2 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 878292-27:
(8*8)+(7*7)+(6*8)+(5*2)+(4*9)+(3*2)+(2*2)+(1*7)=224
224 % 10 = 4
So 878292-27-4 is a valid CAS Registry Number.
InChI:InChI=1/C22H20FN3O3/c1-22(2)21(28)25(3)18-11-15(23)7-8-17(18)26(22)20(27)13-29-19-6-4-5-14-12-24-10-9-16(14)19/h4-12H,13H2,1-3H3
878292-27-4Relevant articles and documents
THERAPEUTIC AGENT FOR IRRITABLE BOWEL SYNDROME
-
, (2011/06/10)
[Problem]The present invention aims to provide an agent for the prophylaxis or treatment of irritable bowel syndrome. [Solving Means]An agent for the prophylaxis or treatment of irritable bowel syndrome, containing a compound having a TGR5 receptor agonist activity, a fused ring compound represented by the formula wherein ring A is an optionally substituted aromatic ring, and ring B' is a 5- to 9-membered ring having one or more substituents, or a salt thereof as an active ingredient.
